SCHEMBL7694096

SCHEMBL7694096

Cc1ccc(SCc2nc3cc4ccccc4cc3nc2CSc2ccc(C)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 8/20 0.50
RAB9A P51151 8/20 0.50
SMN1; SMN2 Q16637 6/20 0.50
ALDH1A1 P00352 4/20 0.50
HPGD P15428 3/20 0.50
MAPT P10636 3/20 0.44
MAPK1 P28482 2/20 0.44
TSHR P16473 1/20 0.44
TDP1 Q9NUW8 3/20 0.41
CASP3 P42574 1/20 0.41
SENP8 Q96LD8 1/20 0.41
SENP7 Q9BQF6 1/20 0.41
SENP6 Q9GZR1 1/20 0.41
RECQL P46063 1/20 0.41
KDM4E B2RXH2 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
LMNA P02545 3/20 0.40
NQO2 P16083 2/20 0.39
HTT P42858 2/20 0.39
CYP1A2 P05177 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7698454 0.86 NQO2 (0.45) NPC1RAB9ASMN1; SMN2ALDH1A1MAPT
SCHEMBL7689877 0.84 SMN1; SMN2 (0.43) NPC1RAB9ASMN1; SMN2ALDH1A1HPGD
SCHEMBL7695589 0.84 APP (0.46) NPC1RAB9ASMN1; SMN2ALDH1A1HPGD
SCHEMBL7691263 0.83 NQO2 (0.39) NPC1RAB9ASMN1; SMN2MAPTLMNA
SCHEMBL7697719 0.83 NPC1 (0.50) NPC1RAB9ASMN1; SMN2ALDH1A1HPGD
SCHEMBL7692496 0.80 SMN1; SMN2 (0.40) SMN1; SMN2ALDH1A1HPGDMAPTTDP1
SCHEMBL7699341 0.80 LMNA (0.45) NPC1RAB9ASMN1; SMN2ALDH1A1HPGD
SCHEMBL7695424 0.78 CYP1A2 (0.42) NPC1RAB9AMAPTNPSR1LMNA
SCHEMBL24115709 0.77 NQO2 (0.49) NPC1RAB9ASMN1; SMN2ALDH1A1HPGD
SCHEMBL7697050 0.74 TDP1 (0.44) ALDH1A1MAPTMAPK1TDP1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002094796-A2 BENZO[G]QUINOXALINE DERIVATIVES AS EFFECTIVE COMPOUNDS AGAINST INFECTIOUS DISEASES AXXIMA PHARMACEUTICALS AG (DE) 2002-11-28 WO disclosed